Current status: 832 hESC lines, 3179 hiPSC lines, and 97 clinical studies, and 417 certificates
Monthly statistic from Jun 1, 2022
Posted on June 1, 2022
total lines | 4011 |
hESC lines | 832 |
hiPSC lines | 3179 |
derivation countries | 43 |
projects | 234 |
providers | 725 |
clinical studies | 97 |
subclones | 1567 |
certificates | 417 |
cell line certificates | 300 |
project certificates | 117 |